Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. Alterity Therapeutics Ltd - ADR
ATHE

Buy ATHE Stock

ATHE
See ATHE stock price and Buy/Sell Alterity Therapeutics Ltd - ADR with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
ATHE

Alterity Therapeutics Ltd - ADR (ATHE)

About Alterity Therapeutics Ltd - ADR (ATHE)

Alterity Therapeutics Ltd. engages in the development of therapeutic drugs designed to treat the underlying causes of degeneration of the brain as the aging process progresses. The firm focuses on Parkinson's movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered ...Read more
Market Cap
$25.14M
1 Year High
$1.40
Volume
36.19k
1 Year Low
$0.56
Price to Earnings Ratio
Open
$0.62
Dividend Rate
High
$0.65
Dividend Yield
Low
$0.62

Community

People who own or watch ATHE stock

ATHE Stock News

ATHE stock rating

What analysts recommend for ATHE stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell
1

ATHE price target

What analysts think ATHE will be worth
Low $0.56
High $3
Current $0.63
Target $3

Events

List of events that could affect ATHE stock.
01Sep

Earnings data Q2 2022

01Sep

Earnings data Q2 2022

Buy ATHE Stock

ATHE
See ATHE stock price and Buy/Sell Alterity Therapeutics Ltd - ADR with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch ATHE stock
  • bernadeauj avatar
  • rmcall12 avatar
  • cmacar avatar
  • evilinktattoos avatar
  • 0630 avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.